cinrebafusp alfa
pieris pharmaceuticals,servier
['prs-343']
$pirs pieris pharmaceuticals announces presentation of positive clinical data for cinrebafusp alpa (prs-343) at 2023 aacr annual meeting 45 seconds delayed.
Democratizing insights.

Not investment advice.